Cidara Therapeutics, Inc. - Common Stock (CDTX) — AI analysis & news
Cidara Therapeutics, Inc. - Common Stock (CDTX) stock: 4 recent news items, slightly positive aggregate sentiment, AI analysis and market context on…
Current sentiment read
Across the last 4 indexed CDTX stories, aggregate finance-aware sentiment is slightly positive (+0.12 on a -1 to +1 scale).
Latest CDTX news
- City Therapeutics allocated no shares to half of IPO orders - report - Investing.com · Investing.com
- City Therapeutics Raises $200 Million in Upsized US IPO · Bloomberg
- CEO, President & Director of Damora Therapeutics Picks Up 2.5% More Stock - simplywall.st · simplywall.st
- Merck licenses a KRAS G12D inhibitor for $400M upfront - endpoints.news · endpoints.news
FAQ
What is the current sentiment for CDTX stock?
Aggregate finance-aware sentiment across the last 4 indexed CDTX news stories is slightly positive (+0.12 on a -1 to +1 scale).